News & Updates

Treatment with a newly developed probiotic blend made up of five strains (Bl-04, Bi-07, HN019, NCFM, and Lpc-37) is safe and leads to better gastrointestinal (GI) well-being as early as day 14, with sustained improvements up to day 30, a recent study has shown. Few adverse events resulting in discontinuation have been reported.

Stone recurrence arises following traditional endoscopic retrograde cholangiopancreatography (ERCP) in nearly half of the patients with recurrent common bile duct stone (CBDS) during long-term follow-up, reports a recent study.

Urgency, or the immediate need to defecate, in patients with ulcerative colitis (UC) is an independent predictor of compromised quality of life (QoL) and future risk of hospitalizations, corticosteroid use, and colectomy, suggests a study.

Several features of computed tomography (CT) imaging are significantly predictive of undergoing at least two necrosectomy sessions for patients with walled-off pancreatic necrosis (WON), suggest the results of a recent study.

A short intervention that addresses the nocebo (negative placebo) effect appears to improve tolerance of tricyclic antidepressants (TCAs), which are commonly used to treat disorders of gut-brain interaction (DGBI), a study has shown.

Primary norfloxacin prophylaxis is both safe and effective in preventing bacterial infections in patients with acute-on-chronic liver failure (ACLF), a study has shown.